AIM: Transcatheter aortic valve implantation (TAVI) is considered an alternative therapy in high risk patients with severe aortic stenosis. Despite this, such a minimally invasive procedure is not free from complications. CASE REPORT: An 86-year-old woman underwent a 26-mm SAPIEN TAVI for aortic valve stenosis. Procedure was complicated by valve embolization into the ascending aorta likely due to a sub-optimal positioning of prosthesis during its deployment. Patient was treated by surgical removal of stent-valve and conventional valve replacement. Patient was discharged from hospital 7 days after surgery. At six months follow-up she was asymptomatic and the valve had a good competence with a mean transaortic gradient of 8 mmHg. CONCLUSIONS: After TAVI prosthesis embolization, conversion to conventional surgical treatment is imperative and can be associated with excellent outcome.
AIM: Transcatheter aortic valve implantation (TAVI) is considered an alternative therapy in high risk patients with severe aortic stenosis. Despite this, such a minimally invasive procedure is not free from complications. CASE REPORT: An 86-year-old woman underwent a 26-mm SAPIEN TAVI for aortic valve stenosis. Procedure was complicated by valve embolization into the ascending aorta likely due to a sub-optimal positioning of prosthesis during its deployment. Patient was treated by surgical removal of stent-valve and conventional valve replacement. Patient was discharged from hospital 7 days after surgery. At six months follow-up she was asymptomatic and the valve had a good competence with a mean transaortic gradient of 8 mmHg. CONCLUSIONS: After TAVI prosthesis embolization, conversion to conventional surgical treatment is imperative and can be associated with excellent outcome.
Authors: Philippe Généreux; Stuart J Head; David A Wood; Susheel K Kodali; Mathew R Williams; Jean-Michel Paradis; Marco Spaziano; A Pieter Kappetein; John G Webb; Alain Cribier; Martin B Leon Journal: Eur Heart J Date: 2012-07-31 Impact factor: 29.983
Authors: Philippe Généreux; Stuart J Head; David A Wood; Susheel K Kodali; Mathew R Williams; Jean-Michel Paradis; Marco Spaziano; A Pieter Kappetein; John G Webb; Alain Cribier; Martin B Leon Journal: Eur Heart J Date: 2012-07-31 Impact factor: 29.983
Authors: Edgar L W Tay; Ronen Gurvitch; Namal Wijeysinghe; Fabian Nietlispach; Jonathon Leipsic; David A Wood; Gerald Yong; Anson Cheung; Jian Ye; Samuel V Lichtenstein; Ronald Carere; Christopher Thompson; John G Webb Journal: JACC Cardiovasc Interv Date: 2011-02 Impact factor: 11.195
Authors: Josep Rodés-Cabau; John G Webb; Anson Cheung; Jian Ye; Eric Dumont; Christopher M Feindel; Mark Osten; Madhu K Natarajan; James L Velianou; Giuseppe Martucci; Benoît DeVarennes; Robert Chisholm; Mark D Peterson; Samuel V Lichtenstein; Fabian Nietlispach; Daniel Doyle; Robert DeLarochellière; Kevin Teoh; Victor Chu; Adrian Dancea; Kevin Lachapelle; Asim Cheema; David Latter; Eric Horlick Journal: J Am Coll Cardiol Date: 2010-01-22 Impact factor: 24.094